NCT02080858View on ClinicalTrials.gov

Triple vs. Dual Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

February 28, 2015

Conditions
Atrial FibrillationAcute Coronary Syndrome
Interventions
DRUG

Ticagrelor + Apixaban + ASA

DRUG

Ticagrelor + Apixaban

Trial Locations (1)

1090

Medical University of Vienna, Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02080858 - Triple vs. Dual Therapy | Biotech Hunter | Biotech Hunter